Adalimumab-adbm Kit
Product Images NDC 0597-0595
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 39 technical images submitted to the FDA as part of the official labeling for Adalimumab-adbm (NDC 0597-0595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Adalimumab 02)
Figure 3 (Study UV I)
Figure 3 (Study UV II)
Image (Adalimumab 05)
Image (Adalimumab 06)
Step 1 (Adalimumab 07)
Step 2 (Adalimumab 08)
Step 3 (Adalimumab 09)
Step 4 (Adalimumab 10)
Step 5 (Adalimumab 11)
Step 6 (Adalimumab 12)
Step 7 (Adalimumab 13)
Step 8 (Adalimumab 14)
Step 9 (Adalimumab 15)
Step 10 (Adalimumab 16)
Step 10 (Adalimumab 17)
Step 11 (Adalimumab 18)
Image (Adalimumab 19)
Image (Adalimumab 20)
Step 1 (Adalimumab 21)
Step 2 (Adalimumab 22)
Step 3 (Adalimumab 23)
Step 4 (Adalimumab 24)
Step 5 (Adalimumab 25)
Step 6 (Adalimumab 26)
Step 7 (Adalimumab 27)
Step 8 (Adalimumab 28)
Step 9 (Adalimumab 29)
Step 10 (Adalimumab 30)
Step 10 (Adalimumab 31)
Step 11 (Adalimumab 32)
Image (Adalimumab 33)
Principal Display Panel (40 mg/0.8 mL Kit Carton)
Principal Display Panel (20 mg/0.4 mL Kit Carton)
Principal Display Panel (10 mg/0.2 mL Kit Carton)
Principal Display Panel (40 mg/0.8 mL Kit Carton)
Principal Display Panel (40 mg/0.8 mL Kit Carton)
Principal Display Panel (40 mg/0.8 mL Kit Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.